MARATTO

article · Qatar medical journal

Short versus long-acting erythropoiesis-stimulating agents for anemia management in Egyptian hemodialysis patients

2024Open accessHelwan University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The Clinicaltrial.gov registration ID is NCT05699109 (26/01/2023).

Research topics

  • Erythropoietin and Anemia Treatment
  • Dialysis and Renal Disease Management
  • Iron Metabolism and Disorders

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.5339/qmj.2024.16

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.